Detailed Mechanism Funding and Narrative

Years of mechanism: 2015 2016 2017

Details for Mechanism ID: 17860
Country/Region: Asia Regional Program
Year: 2017
Main Partner: Bangkok Metropolitan Administration
Main Partner Program: NA
Organizational Type: Host Country Government Agency
Funding Agency: HHS/CDC
Total Funding: $300,000 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $68,678
Laboratory Infrastructure (HLAB) $12,900
Strategic Information (HVSI) $67,007
Health Systems Strengthening (OHSS) $36,450
Testing: HIV Testing and Counseling (HVCT) $70,750
Sexual Prevention: Other Sexual Prevention (HVOP) $24,393
Treatment: Adult Treatment (HTXS) $19,822
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST By Key Population: MSM, Negative 2018 319
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 400
HTS_TST Service Delivery Point Agg Age (Facility) VCT: 15+, Male, Negative 2018 319
HTS_TST Sum of Test Result disaggregates 2018 81
HTS_TST_POS By Key Population: MSM, Positive 2018 81
HTS_TST_POS By Test Result: Positive 2018 81
HTS_TST_POS Service Delivery Point Agg Age (Facility) VCT: 15+, Male, Positive 2018 81
KP_PREV By key population type: Men who have sex with men and are NOT sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2018 400
KP_PREV Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2018 400
TX_CURR Aggregated Age/Sex: 15+ Female 2018 3,046
TX_CURR Aggregated Age/Sex: 15+ Male 2018 4,569
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2018 7,615
TX_CURR Sum of Aggregated Age/Sex 15+ 2018 7,615
TX_CURR Sum of Aggregated Age/Sex disaggregates 2018 7,615
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2018 287
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2018 429
TX_NEW MSM 2018 140
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 716
TX_NEW Sum of Aggregated Age/Sex disaggregates 2018 716
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2018 5,340
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2018 5,073
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 2,030
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 3,043
TX_PVLS Numerator: Indication: Routine 2018 5,073
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 2,136
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 3,204
TX_PVLS_den Denominator: Indication: Routine 2018 5,340
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 257
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 389
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2018 646
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2018 716
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 287
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 429
Cross Cutting Budget Categories and Known Amounts Total: $180,000
Key Populations: MSM and TG $45,000
Implementation of core HIV prevention interventions for MSM/TG that are consistent with the current PEPFAR technical guidance
Collection and use of strategic information
Conducting epidemiologic, social science, and operational research among MSM/TG and their sex partners
Human Resources for Health $135,000